We are live on ! Find out more
RE

RBC Europe Portfolio holdings

AUM $2.08B
1-Year Est. Return 12.2%
This Fund
S&P 500
This Quarter Est. Return
+14.63%
1 Year Est. Return
-12.2%
3 Year Est. Return
+59.81%
5 Year Est. Return
+127.03%
10 Year Est. Return
AUM
$905M
AUM Growth
+$139M
Cap. Flow
+$35.2M
Cap. Flow %
3.89%
Top 10 Hldgs %
45.34%
Holding
1,131
New
35
Increased
129
Reduced
172
Closed
48

Top Buys

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$9.41M
2
MSFT icon
Microsoft
MSFT
+$5.02M
3
V icon
Visa
V
+$4.84M
4
AMZN icon
Amazon
AMZN
+$3.59M
5
KOS icon
Kosmos Energy
KOS
+$3.47M

Top Sells

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$2.78M
2
NVDA icon
NVIDIA
NVDA
+$2.65M
3
MDLZ icon
Mondelez International
MDLZ
+$782K
4
EL icon
Estee Lauder
EL
+$772K
5
PFE icon
Pfizer
PFE
+$666K

Sector Composition

Rank Sector Weight
1 Financials 23.17%
2 Technology 17.19%
3 Consumer Discretionary 16.88%
4 Communication Services 11.83%
5 Healthcare 9.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SDLP
976
DELISTED
SEADRILL PARTNERS LLC
SDLP
$2.78K ﹤0.01%
325
ADTN icon
977
Adtran
ADTN
$629M
$2.74K ﹤0.01%
200
KKR icon
978
KKR & Co
KKR
$97.6B
$2.68K ﹤0.01%
114
PGEN icon
979
Precigen
PGEN
$2.49B
$2.63K ﹤0.01%
500
ADAP
980
DELISTED
Adaptimmune Therapeutics
ADAP
$2.58K ﹤0.01%
600
NEWR
981
DELISTED
New Relic, Inc.
NEWR
$2.57K ﹤0.01%
26
NLY icon
982
Annaly Capital Management
NLY
$17.4B
$2.55K ﹤0.01%
64
RRD
983
DELISTED
RR Donnelley & Sons Co.
RRD
$2.52K ﹤0.01%
533
AA icon
984
Alcoa
AA
$13.3B
$2.51K ﹤0.01%
89
-2,442
-96% -$69.8K
XBIO icon
985
Xenetic Biosciences
XBIO
$9.33M
$2.47K ﹤0.01%
11
KF
986
Korea Fund
KF
$267M
$2.44K ﹤0.01%
83
BRS
987
DELISTED
Bristow Group, Inc.
BRS
$2.44K ﹤0.01%
2,200
NBRV
988
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$2.44K ﹤0.01%
4
URA icon
989
Global X Uranium ETF
URA
$6.39B
$2.44K ﹤0.01%
195
EWP icon
990
iShares MSCI Spain ETF
EWP
$2.24B
$2.43K ﹤0.01%
85
FOX icon
991
Fox Class B
FOX
$25.8B
$2.37K ﹤0.01%
+66
New +$2.52K
SER icon
992
Serina Therapeutics
SER
$62.5M
$2.31K ﹤0.01%
16
RDC
993
DELISTED
Rowan Companies Plc
RDC
$2.27K ﹤0.01%
210
CRTO icon
994
Criteo S.A.
CRTO
$855M
$2.26K ﹤0.01%
113
NAK
995
Northern Dynasty Minerals
NAK
$944M
$2.05K ﹤0.01%
3,400
DFRG
996
DELISTED
Del Frisco's Restaurant Group, Inc. Common Stock
DFRG
$1.99K ﹤0.01%
310
NOK icon
997
Nokia
NOK
$57.2B
$1.89K ﹤0.01%
330
NVAX icon
998
Novavax
NVAX
$1.53B
$1.81K ﹤0.01%
165
SKF icon
999
ProShares UltraShort Financials
SKF
$10.5M
$1.81K ﹤0.01%
6
PRLB icon
1000
Protolabs
PRLB
$1.91B
$1.79K ﹤0.01%
17

Similar funds

RBC Europe's Q1 2019 Portfolio in Review

As of Q1 2019, RBC Europe held 1,131 positions worth $905M, up 18% from $767M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

RBC Europe deployed $35.2M of net new capital in Q1 2019, opening 35 new positions and adding to 129 existing holdings. Its largest new stake was Kosmos Energy: 626,188 shares worth $3.9M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, down from 23% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Activision Blizzard, an estimated $2.78M trimmed.

  • RBC Europe's largest Q1 2019 buy was Kosmos Energy: 626,188 shares worth $3.9M.
  • RBC Europe added most to Berkshire Hathaway Class B in Q1 2019, an estimated $9.41M increase.
  • RBC Europe's biggest Q1 2019 reduction was Activision Blizzard, cutting an estimated $2.78M.
  • RBC Europe fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $490K.
  • RBC Europe's ten largest holdings make up 45% of its $905M portfolio in Q1 2019.
  • RBC Europe opened 35 new positions and closed 48 in Q1 2019.
  • RBC Europe's portfolio value rose 18% quarter-over-quarter to $905M.

Based on RBC Europe's 13F filing for Q1 2019, filed 9 Nov 2023.